15th October 2021
15th October 2021
Registration will allow you to submit your questions for the panel and ensure access to the webcast post-event if you are unable to join live.
An international panel of MS experts will answer questions submitted by people affected by MS from throughout the world. From ways to manage or reduce fatigue to research seeking the cause and developing new treatments, this webcast will provide information to help improve quality of life and keep you informed.
Sponsored by Sanofi Genzyme and Genentech, A Member of the Roche Group
Tuesday, 9 November, 2021 at 4:00 pm GMT, 5:00 pm CEST, 11 am ESTRegister now
Angela White has been a leader in the MS movement since her diagnosis of multiple sclerosis in 2002. As volunteer for the National MS Society, U.S., she has advocated for needed change in public policy, served as a committee member of the Black MS Experience Summit and reviewed MS research applications as well as a myriad of other roles. She also is engaged in the MS International Federation’s Patient Reported Outcomes Initiative.
Dr. Stefan Gold is the Heisenberg Professor of Neuropsychiatry in the Department of Psychiatry, Charité Medical School in Berlin, Germany. As a clinician and researcher, he focuses on complex symptoms in MS, including depression, cognition and fatigue. His work examines biological causes in order to improve existing treatments and to discover novel interventions to manage these debilitating symptoms. He has published numerous papers regarding MS and serves on the International Progressive MS Improving Well-Being Scientific Working Group.
Dr. Jaume Sastre-Garriga is a neurologist at the Neuroimmunology and MS Centre of Catalonia in Barcelona, Spain. He has served in a number of leadership positions in MS treatment and research internationally and published over 100 papers. He serves as the director of the journal, Revista de Neurlogica, and is on the editorial committee of the Multiple Sclerosis Journal. His research interests include functional and structural MRI and neurorehabilitation, with a particular focus on progressive MS. He serves on the International Progressive MS Improving Well-Being Scientific Working Group.